鼻腔内粘膜噴霧装置のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Intranasal Mucosal Atomization Device Market Insights, Forecast to 2028

• レポートコード：QY2207E09614 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の鼻腔内粘膜噴霧装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に鼻腔内粘膜噴霧装置の世界市場のxxx％を占める「ガス推進式アトマイザー」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院・クリニック」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の鼻腔内粘膜噴霧装置の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの鼻腔内粘膜噴霧装置市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの鼻腔内粘膜噴霧装置市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 鼻腔内粘膜噴霧装置のグローバル主要メーカーには、Teleflex、Drive Medical、BD、MILA International、Cook Medical、Medica Holdings、Kurve Technologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 鼻腔内粘膜噴霧装置市場は、種類と用途によって区分されます。世界の鼻腔内粘膜噴霧装置市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ガス推進式アトマイザー、電子式アトマイザー 【用途別セグメント】 病院・クリニック、外来手術センター 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 鼻腔内粘膜噴霧装置製品概要 - 種類別市場（ガス推進式アトマイザー、電子式アトマイザー） - 用途別市場（病院・クリニック、外来手術センター） - 調査の目的 ・エグゼクティブサマリー - 世界の鼻腔内粘膜噴霧装置販売量予測2017-2028 - 世界の鼻腔内粘膜噴霧装置売上予測2017-2028 - 鼻腔内粘膜噴霧装置の地域別販売量 - 鼻腔内粘膜噴霧装置の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別鼻腔内粘膜噴霧装置販売量 - 主要メーカー別鼻腔内粘膜噴霧装置売上 - 主要メーカー別鼻腔内粘膜噴霧装置価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ガス推進式アトマイザー、電子式アトマイザー） - 鼻腔内粘膜噴霧装置の種類別販売量 - 鼻腔内粘膜噴霧装置の種類別売上 - 鼻腔内粘膜噴霧装置の種類別価格 ・用途別市場規模（病院・クリニック、外来手術センター） - 鼻腔内粘膜噴霧装置の用途別販売量 - 鼻腔内粘膜噴霧装置の用途別売上 - 鼻腔内粘膜噴霧装置の用途別価格 ・北米市場 - 北米の鼻腔内粘膜噴霧装置市場規模（種類別、用途別） - 主要国別の鼻腔内粘膜噴霧装置市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの鼻腔内粘膜噴霧装置市場規模（種類別、用途別） - 主要国別の鼻腔内粘膜噴霧装置市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の鼻腔内粘膜噴霧装置市場規模（種類別、用途別） - 主要国別の鼻腔内粘膜噴霧装置市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の鼻腔内粘膜噴霧装置市場規模（種類別、用途別） - 主要国別の鼻腔内粘膜噴霧装置市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの鼻腔内粘膜噴霧装置市場規模（種類別、用途別） - 主要国別の鼻腔内粘膜噴霧装置市場規模（トルコ、サウジアラビア） ・企業情報 Teleflex、Drive Medical、BD、MILA International、Cook Medical、Medica Holdings、Kurve Technology ・産業チェーン及び販売チャネル分析 - 鼻腔内粘膜噴霧装置の産業チェーン分析 - 鼻腔内粘膜噴霧装置の原材料 - 鼻腔内粘膜噴霧装置の生産プロセス - 鼻腔内粘膜噴霧装置の販売及びマーケティング - 鼻腔内粘膜噴霧装置の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 鼻腔内粘膜噴霧装置の産業動向 - 鼻腔内粘膜噴霧装置のマーケットドライバー - 鼻腔内粘膜噴霧装置の課題 - 鼻腔内粘膜噴霧装置の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Intranasal Mucosal Atomization Device Market
Due to the COVID-19 pandemic, the global Intranasal Mucosal Atomization Device market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Gas Propulsion Atomizer accounting for % of the Intranasal Mucosal Atomization Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals and Clinics segment is altered to an % CAGR throughout this forecast period.
China Intranasal Mucosal Atomization Device market size is valued at US$ million in 2021, while the US and Europe Intranasal Mucosal Atomization Device are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Intranasal Mucosal Atomization Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Intranasal Mucosal Atomization Device include Teleflex, Drive Medical, BD, MILA International, Cook Medical, Medica Holdings and Kurve Technology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Intranasal Mucosal Atomization Device Scope and Segment
Intranasal Mucosal Atomization Device market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Intranasal Mucosal Atomization Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Gas Propulsion Atomizer
Electronic Atomizer
Segment by Application
Hospitals and Clinics
Ambulatory Surgery Center
By Company
Teleflex
Drive Medical
BD
MILA International
Cook Medical
Medica Holdings
Kurve Technology
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Intranasal Mucosal Atomization Device Product Introduction
1.2 Market by Type
1.2.1 Global Intranasal Mucosal Atomization Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Gas Propulsion Atomizer
1.2.3 Electronic Atomizer
1.3 Market by Application
1.3.1 Global Intranasal Mucosal Atomization Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Ambulatory Surgery Center
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intranasal Mucosal Atomization Device Sales Estimates and Forecasts 2017-2028
2.2 Global Intranasal Mucosal Atomization Device Revenue Estimates and Forecasts 2017-2028
2.3 Global Intranasal Mucosal Atomization Device Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Intranasal Mucosal Atomization Device Sales by Region
2.4.1 Global Intranasal Mucosal Atomization Device Sales by Region (2017-2022)
2.4.2 Global Sales Intranasal Mucosal Atomization Device by Region (2023-2028)
2.5 Global Intranasal Mucosal Atomization Device Revenue by Region
2.5.1 Global Intranasal Mucosal Atomization Device Revenue by Region (2017-2022)
2.5.2 Global Intranasal Mucosal Atomization Device Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Intranasal Mucosal Atomization Device Sales by Manufacturers
3.1.1 Global Top Intranasal Mucosal Atomization Device Manufacturers by Sales (2017-2022)
3.1.2 Global Intranasal Mucosal Atomization Device Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intranasal Mucosal Atomization Device in 2021
3.2 Global Intranasal Mucosal Atomization Device Revenue by Manufacturers
3.2.1 Global Intranasal Mucosal Atomization Device Revenue by Manufacturers (2017-2022)
3.2.2 Global Intranasal Mucosal Atomization Device Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Intranasal Mucosal Atomization Device Revenue in 2021
3.3 Global Intranasal Mucosal Atomization Device Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Intranasal Mucosal Atomization Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Intranasal Mucosal Atomization Device Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intranasal Mucosal Atomization Device Sales by Type
4.1.1 Global Intranasal Mucosal Atomization Device Historical Sales by Type (2017-2022)
4.1.2 Global Intranasal Mucosal Atomization Device Forecasted Sales by Type (2023-2028)
4.1.3 Global Intranasal Mucosal Atomization Device Sales Market Share by Type (2017-2028)
4.2 Global Intranasal Mucosal Atomization Device Revenue by Type
4.2.1 Global Intranasal Mucosal Atomization Device Historical Revenue by Type (2017-2022)
4.2.2 Global Intranasal Mucosal Atomization Device Forecasted Revenue by Type (2023-2028)
4.2.3 Global Intranasal Mucosal Atomization Device Revenue Market Share by Type (2017-2028)
4.3 Global Intranasal Mucosal Atomization Device Price by Type
4.3.1 Global Intranasal Mucosal Atomization Device Price by Type (2017-2022)
4.3.2 Global Intranasal Mucosal Atomization Device Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Intranasal Mucosal Atomization Device Sales by Application
5.1.1 Global Intranasal Mucosal Atomization Device Historical Sales by Application (2017-2022)
5.1.2 Global Intranasal Mucosal Atomization Device Forecasted Sales by Application (2023-2028)
5.1.3 Global Intranasal Mucosal Atomization Device Sales Market Share by Application (2017-2028)
5.2 Global Intranasal Mucosal Atomization Device Revenue by Application
5.2.1 Global Intranasal Mucosal Atomization Device Historical Revenue by Application (2017-2022)
5.2.2 Global Intranasal Mucosal Atomization Device Forecasted Revenue by Application (2023-2028)
5.2.3 Global Intranasal Mucosal Atomization Device Revenue Market Share by Application (2017-2028)
5.3 Global Intranasal Mucosal Atomization Device Price by Application
5.3.1 Global Intranasal Mucosal Atomization Device Price by Application (2017-2022)
5.3.2 Global Intranasal Mucosal Atomization Device Price Forecast by Application (2023-2028)
6 North America
6.1 North America Intranasal Mucosal Atomization Device Market Size by Type
6.1.1 North America Intranasal Mucosal Atomization Device Sales by Type (2017-2028)
6.1.2 North America Intranasal Mucosal Atomization Device Revenue by Type (2017-2028)
6.2 North America Intranasal Mucosal Atomization Device Market Size by Application
6.2.1 North America Intranasal Mucosal Atomization Device Sales by Application (2017-2028)
6.2.2 North America Intranasal Mucosal Atomization Device Revenue by Application (2017-2028)
6.3 North America Intranasal Mucosal Atomization Device Market Size by Country
6.3.1 North America Intranasal Mucosal Atomization Device Sales by Country (2017-2028)
6.3.2 North America Intranasal Mucosal Atomization Device Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Intranasal Mucosal Atomization Device Market Size by Type
7.1.1 Europe Intranasal Mucosal Atomization Device Sales by Type (2017-2028)
7.1.2 Europe Intranasal Mucosal Atomization Device Revenue by Type (2017-2028)
7.2 Europe Intranasal Mucosal Atomization Device Market Size by Application
7.2.1 Europe Intranasal Mucosal Atomization Device Sales by Application (2017-2028)
7.2.2 Europe Intranasal Mucosal Atomization Device Revenue by Application (2017-2028)
7.3 Europe Intranasal Mucosal Atomization Device Market Size by Country
7.3.1 Europe Intranasal Mucosal Atomization Device Sales by Country (2017-2028)
7.3.2 Europe Intranasal Mucosal Atomization Device Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Intranasal Mucosal Atomization Device Market Size by Type
8.1.1 Asia Pacific Intranasal Mucosal Atomization Device Sales by Type (2017-2028)
8.1.2 Asia Pacific Intranasal Mucosal Atomization Device Revenue by Type (2017-2028)
8.2 Asia Pacific Intranasal Mucosal Atomization Device Market Size by Application
8.2.1 Asia Pacific Intranasal Mucosal Atomization Device Sales by Application (2017-2028)
8.2.2 Asia Pacific Intranasal Mucosal Atomization Device Revenue by Application (2017-2028)
8.3 Asia Pacific Intranasal Mucosal Atomization Device Market Size by Region
8.3.1 Asia Pacific Intranasal Mucosal Atomization Device Sales by Region (2017-2028)
8.3.2 Asia Pacific Intranasal Mucosal Atomization Device Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Intranasal Mucosal Atomization Device Market Size by Type
9.1.1 Latin America Intranasal Mucosal Atomization Device Sales by Type (2017-2028)
9.1.2 Latin America Intranasal Mucosal Atomization Device Revenue by Type (2017-2028)
9.2 Latin America Intranasal Mucosal Atomization Device Market Size by Application
9.2.1 Latin America Intranasal Mucosal Atomization Device Sales by Application (2017-2028)
9.2.2 Latin America Intranasal Mucosal Atomization Device Revenue by Application (2017-2028)
9.3 Latin America Intranasal Mucosal Atomization Device Market Size by Country
9.3.1 Latin America Intranasal Mucosal Atomization Device Sales by Country (2017-2028)
9.3.2 Latin America Intranasal Mucosal Atomization Device Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Intranasal Mucosal Atomization Device Market Size by Type
10.1.1 Middle East and Africa Intranasal Mucosal Atomization Device Sales by Type (2017-2028)
10.1.2 Middle East and Africa Intranasal Mucosal Atomization Device Revenue by Type (2017-2028)
10.2 Middle East and Africa Intranasal Mucosal Atomization Device Market Size by Application
10.2.1 Middle East and Africa Intranasal Mucosal Atomization Device Sales by Application (2017-2028)
10.2.2 Middle East and Africa Intranasal Mucosal Atomization Device Revenue by Application (2017-2028)
10.3 Middle East and Africa Intranasal Mucosal Atomization Device Market Size by Country
10.3.1 Middle East and Africa Intranasal Mucosal Atomization Device Sales by Country (2017-2028)
10.3.2 Middle East and Africa Intranasal Mucosal Atomization Device Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teleflex
11.1.1 Teleflex Corporation Information
11.1.2 Teleflex Overview
11.1.3 Teleflex Intranasal Mucosal Atomization Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teleflex Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teleflex Recent Developments
11.2 Drive Medical
11.2.1 Drive Medical Corporation Information
11.2.2 Drive Medical Overview
11.2.3 Drive Medical Intranasal Mucosal Atomization Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Drive Medical Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Drive Medical Recent Developments
11.3 BD
11.3.1 BD Corporation Information
11.3.2 BD Overview
11.3.3 BD Intranasal Mucosal Atomization Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 BD Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BD Recent Developments
11.4 MILA International
11.4.1 MILA International Corporation Information
11.4.2 MILA International Overview
11.4.3 MILA International Intranasal Mucosal Atomization Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 MILA International Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MILA International Recent Developments
11.5 Cook Medical
11.5.1 Cook Medical Corporation Information
11.5.2 Cook Medical Overview
11.5.3 Cook Medical Intranasal Mucosal Atomization Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Cook Medical Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cook Medical Recent Developments
11.6 Medica Holdings
11.6.1 Medica Holdings Corporation Information
11.6.2 Medica Holdings Overview
11.6.3 Medica Holdings Intranasal Mucosal Atomization Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Medica Holdings Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Medica Holdings Recent Developments
11.7 Kurve Technology
11.7.1 Kurve Technology Corporation Information
11.7.2 Kurve Technology Overview
11.7.3 Kurve Technology Intranasal Mucosal Atomization Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Kurve Technology Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Kurve Technology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intranasal Mucosal Atomization Device Industry Chain Analysis
12.2 Intranasal Mucosal Atomization Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intranasal Mucosal Atomization Device Production Mode & Process
12.4 Intranasal Mucosal Atomization Device Sales and Marketing
12.4.1 Intranasal Mucosal Atomization Device Sales Channels
12.4.2 Intranasal Mucosal Atomization Device Distributors
12.5 Intranasal Mucosal Atomization Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Intranasal Mucosal Atomization Device Industry Trends
13.2 Intranasal Mucosal Atomization Device Market Drivers
13.3 Intranasal Mucosal Atomization Device Market Challenges
13.4 Intranasal Mucosal Atomization Device Market Restraints
14 Key Findings in The Global Intranasal Mucosal Atomization Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Intranasal Mucosal Atomization Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Gas Propulsion Atomizer
Table 3. Major Manufacturers of Electronic Atomizer
Table 4. Global Intranasal Mucosal Atomization Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Intranasal Mucosal Atomization Device Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Intranasal Mucosal Atomization Device Sales by Region (2017-2022) & (K Units)
Table 7. Global Intranasal Mucosal Atomization Device Sales Market Share by Region (2017-2022)
Table 8. Global Intranasal Mucosal Atomization Device Sales by Region (2023-2028) & (K Units)
Table 9. Global Intranasal Mucosal Atomization Device Sales Market Share by Region (2023-2028)
Table 10. Global Intranasal Mucosal Atomization Device Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Intranasal Mucosal Atomization Device Revenue Market Share by Region (2017-2022)
Table 12. Global Intranasal Mucosal Atomization Device Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Intranasal Mucosal Atomization Device Revenue Market Share by Region (2023-2028)
Table 14. Global Intranasal Mucosal Atomization Device Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Intranasal Mucosal Atomization Device Sales Share by Manufacturers (2017-2022)
Table 16. Global Intranasal Mucosal Atomization Device Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Intranasal Mucosal Atomization Device Revenue Share by Manufacturers (2017-2022)
Table 18. Intranasal Mucosal Atomization Device Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Intranasal Mucosal Atomization Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Intranasal Mucosal Atomization Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Mucosal Atomization Device as of 2021)
Table 21. Intranasal Mucosal Atomization Device Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Intranasal Mucosal Atomization Device Product Offered
Table 23. Date of Manufacturers Enter into Intranasal Mucosal Atomization Device Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Intranasal Mucosal Atomization Device Sales by Type (2017-2022) & (K Units)
Table 26. Global Intranasal Mucosal Atomization Device Sales by Type (2023-2028) & (K Units)
Table 27. Global Intranasal Mucosal Atomization Device Sales Share by Type (2017-2022)
Table 28. Global Intranasal Mucosal Atomization Device Sales Share by Type (2023-2028)
Table 29. Global Intranasal Mucosal Atomization Device Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Intranasal Mucosal Atomization Device Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Intranasal Mucosal Atomization Device Revenue Share by Type (2017-2022)
Table 32. Global Intranasal Mucosal Atomization Device Revenue Share by Type (2023-2028)
Table 33. Intranasal Mucosal Atomization Device Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Intranasal Mucosal Atomization Device Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Intranasal Mucosal Atomization Device Sales by Application (2017-2022) & (K Units)
Table 36. Global Intranasal Mucosal Atomization Device Sales by Application (2023-2028) & (K Units)
Table 37. Global Intranasal Mucosal Atomization Device Sales Share by Application (2017-2022)
Table 38. Global Intranasal Mucosal Atomization Device Sales Share by Application (2023-2028)
Table 39. Global Intranasal Mucosal Atomization Device Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Intranasal Mucosal Atomization Device Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Intranasal Mucosal Atomization Device Revenue Share by Application (2017-2022)
Table 42. Global Intranasal Mucosal Atomization Device Revenue Share by Application (2023-2028)
Table 43. Intranasal Mucosal Atomization Device Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Intranasal Mucosal Atomization Device Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Intranasal Mucosal Atomization Device Sales by Type (2017-2022) & (K Units)
Table 46. North America Intranasal Mucosal Atomization Device Sales by Type (2023-2028) & (K Units)
Table 47. North America Intranasal Mucosal Atomization Device Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Intranasal Mucosal Atomization Device Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Intranasal Mucosal Atomization Device Sales by Application (2017-2022) & (K Units)
Table 50. North America Intranasal Mucosal Atomization Device Sales by Application (2023-2028) & (K Units)
Table 51. North America Intranasal Mucosal Atomization Device Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Intranasal Mucosal Atomization Device Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Intranasal Mucosal Atomization Device Sales by Country (2017-2022) & (K Units)
Table 54. North America Intranasal Mucosal Atomization Device Sales by Country (2023-2028) & (K Units)
Table 55. North America Intranasal Mucosal Atomization Device Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Intranasal Mucosal Atomization Device Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Intranasal Mucosal Atomization Device Sales by Type (2017-2022) & (K Units)
Table 58. Europe Intranasal Mucosal Atomization Device Sales by Type (2023-2028) & (K Units)
Table 59. Europe Intranasal Mucosal Atomization Device Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Intranasal Mucosal Atomization Device Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Intranasal Mucosal Atomization Device Sales by Application (2017-2022) & (K Units)
Table 62. Europe Intranasal Mucosal Atomization Device Sales by Application (2023-2028) & (K Units)
Table 63. Europe Intranasal Mucosal Atomization Device Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Intranasal Mucosal Atomization Device Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Intranasal Mucosal Atomization Device Sales by Country (2017-2022) & (K Units)
Table 66. Europe Intranasal Mucosal Atomization Device Sales by Country (2023-2028) & (K Units)
Table 67. Europe Intranasal Mucosal Atomization Device Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Intranasal Mucosal Atomization Device Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Intranasal Mucosal Atomization Device Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Intranasal Mucosal Atomization Device Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Intranasal Mucosal Atomization Device Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Intranasal Mucosal Atomization Device Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Intranasal Mucosal Atomization Device Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Intranasal Mucosal Atomization Device Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Intranasal Mucosal Atomization Device Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Intranasal Mucosal Atomization Device Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Intranasal Mucosal Atomization Device Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Intranasal Mucosal Atomization Device Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Intranasal Mucosal Atomization Device Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Intranasal Mucosal Atomization Device Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Intranasal Mucosal Atomization Device Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Intranasal Mucosal Atomization Device Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Intranasal Mucosal Atomization Device Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Intranasal Mucosal Atomization Device Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Intranasal Mucosal Atomization Device Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Intranasal Mucosal Atomization Device Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Intranasal Mucosal Atomization Device Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Intranasal Mucosal Atomization Device Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Intranasal Mucosal Atomization Device Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Intranasal Mucosal Atomization Device Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Intranasal Mucosal Atomization Device Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Intranasal Mucosal Atomization Device Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Intranasal Mucosal Atomization Device Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Intranasal Mucosal Atomization Device Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Intranasal Mucosal Atomization Device Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Intranasal Mucosal Atomization Device Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Intranasal Mucosal Atomization Device Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Intranasal Mucosal Atomization Device Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Intranasal Mucosal Atomization Device Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Intranasal Mucosal Atomization Device Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Intranasal Mucosal Atomization Device Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Intranasal Mucosal Atomization Device Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Intranasal Mucosal Atomization Device Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Intranasal Mucosal Atomization Device Revenue by Country (2023-2028) & (US$ Million)
Table 105. Teleflex Corporation Information
Table 106. Teleflex Description and Major Businesses
Table 107. Teleflex Intranasal Mucosal Atomization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Teleflex Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Teleflex Recent Developments
Table 110. Drive Medical Corporation Information
Table 111. Drive Medical Description and Major Businesses
Table 112. Drive Medical Intranasal Mucosal Atomization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Drive Medical Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Drive Medical Recent Developments
Table 115. BD Corporation Information
Table 116. BD Description and Major Businesses
Table 117. BD Intranasal Mucosal Atomization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. BD Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. BD Recent Developments
Table 120. MILA International Corporation Information
Table 121. MILA International Description and Major Businesses
Table 122. MILA International Intranasal Mucosal Atomization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. MILA International Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. MILA International Recent Developments
Table 125. Cook Medical Corporation Information
Table 126. Cook Medical Description and Major Businesses
Table 127. Cook Medical Intranasal Mucosal Atomization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Cook Medical Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Cook Medical Recent Developments
Table 130. Medica Holdings Corporation Information
Table 131. Medica Holdings Description and Major Businesses
Table 132. Medica Holdings Intranasal Mucosal Atomization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Medica Holdings Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Medica Holdings Recent Developments
Table 135. Kurve Technology Corporation Information
Table 136. Kurve Technology Description and Major Businesses
Table 137. Kurve Technology Intranasal Mucosal Atomization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Kurve Technology Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Kurve Technology Recent Developments
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Intranasal Mucosal Atomization Device Distributors List
Table 143. Intranasal Mucosal Atomization Device Customers List
Table 144. Intranasal Mucosal Atomization Device Market Trends
Table 145. Intranasal Mucosal Atomization Device Market Drivers
Table 146. Intranasal Mucosal Atomization Device Market Challenges
Table 147. Intranasal Mucosal Atomization Device Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Intranasal Mucosal Atomization Device Product Picture
Figure 3. Global Intranasal Mucosal Atomization Device Market Share by Type in 2021 & 2028
Figure 3. Gas Propulsion Atomizer Product Picture
Figure 4. Electronic Atomizer Product Picture
Figure 5. Global Intranasal Mucosal Atomization Device Market Share by Application in 2021 & 2028
Figure 6. Hospitals and Clinics
Figure 7. Ambulatory Surgery Center
Figure 8. Intranasal Mucosal Atomization Device Report Years Considered
Figure 9. Global Intranasal Mucosal Atomization Device Sales 2017-2028 (K Units)
Figure 10. Global Intranasal Mucosal Atomization Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Intranasal Mucosal Atomization Device Revenue 2017-2028 (US$ Million)
Figure 12. Global Intranasal Mucosal Atomization Device Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Intranasal Mucosal Atomization Device Sales Market Share by Region (2017-2022)
Figure 14. Global Intranasal Mucosal Atomization Device Sales Market Share by Region (2023-2028)
Figure 15. North America Intranasal Mucosal Atomization Device Sales YoY (2017-2028) & (K Units)
Figure 16. North America Intranasal Mucosal Atomization Device Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Intranasal Mucosal Atomization Device Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Intranasal Mucosal Atomization Device Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Intranasal Mucosal Atomization Device Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Intranasal Mucosal Atomization Device Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Intranasal Mucosal Atomization Device Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Intranasal Mucosal Atomization Device Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Intranasal Mucosal Atomization Device Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Intranasal Mucosal Atomization Device Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Intranasal Mucosal Atomization Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Intranasal Mucosal Atomization Device in the World: Market Share by Intranasal Mucosal Atomization Device Revenue in 2021
Figure 27. Global Intranasal Mucosal Atomization Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Intranasal Mucosal Atomization Device Sales Market Share by Type (2017-2028)
Figure 29. Global Intranasal Mucosal Atomization Device Revenue Market Share by Type (2017-2028)
Figure 30. Global Intranasal Mucosal Atomization Device Sales Market Share by Application (2017-2028)
Figure 31. Global Intranasal Mucosal Atomization Device Revenue Market Share by Application (2017-2028)
Figure 32. North America Intranasal Mucosal Atomization Device Sales Market Share by Type (2017-2028)
Figure 33. North America Intranasal Mucosal Atomization Device Revenue Market Share by Type (2017-2028)
Figure 34. North America Intranasal Mucosal Atomization Device Sales Market Share by Application (2017-2028)
Figure 35. North America Intranasal Mucosal Atomization Device Revenue Market Share by Application (2017-2028)
Figure 36. North America Intranasal Mucosal Atomization Device Sales Share by Country (2017-2028)
Figure 37. North America Intranasal Mucosal Atomization Device Revenue Share by Country (2017-2028)
Figure 38. United States Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Intranasal Mucosal Atomization Device Sales Market Share by Type (2017-2028)
Figure 41. Europe Intranasal Mucosal Atomization Device Revenue Market Share by Type (2017-2028)
Figure 42. Europe Intranasal Mucosal Atomization Device Sales Market Share by Application (2017-2028)
Figure 43. Europe Intranasal Mucosal Atomization Device Revenue Market Share by Application (2017-2028)
Figure 44. Europe Intranasal Mucosal Atomization Device Sales Share by Country (2017-2028)
Figure 45. Europe Intranasal Mucosal Atomization Device Revenue Share by Country (2017-2028)
Figure 46. Germany Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 47. France Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Intranasal Mucosal Atomization Device Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Intranasal Mucosal Atomization Device Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Intranasal Mucosal Atomization Device Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Intranasal Mucosal Atomization Device Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Intranasal Mucosal Atomization Device Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Intranasal Mucosal Atomization Device Revenue Share by Region (2017-2028)
Figure 57. China Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 60. India Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Intranasal Mucosal Atomization Device Sales Market Share by Type (2017-2028)
Figure 67. Latin America Intranasal Mucosal Atomization Device Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Intranasal Mucosal Atomization Device Sales Market Share by Application (2017-2028)
Figure 69. Latin America Intranasal Mucosal Atomization Device Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Intranasal Mucosal Atomization Device Sales Share by Country (2017-2028)
Figure 71. Latin America Intranasal Mucosal Atomization Device Revenue Share by Country (2017-2028)
Figure 72. Mexico Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 75. Colombia Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Intranasal Mucosal Atomization Device Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Intranasal Mucosal Atomization Device Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Intranasal Mucosal Atomization Device Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Intranasal Mucosal Atomization Device Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Intranasal Mucosal Atomization Device Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Intranasal Mucosal Atomization Device Revenue Share by Country (2017-2028)
Figure 82. Turkey Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Intranasal Mucosal Atomization Device Revenue (2017-2028) & (US$ Million)
Figure 85. Intranasal Mucosal Atomization Device Value Chain
Figure 86. Intranasal Mucosal Atomization Device Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

---